OMass Therapeutics

The company uses proprietary biochemistry, native mass spectrometry, and custom chemistry to discover small molecule drugs for immunology and rare diseases. Its platform interrogates how drug targets interact within their native ecosystems to identify novel medicines. This approach aims to understand complex protein interactions separate from the confounding complexity of the cell.